Martin A. Lehr - Net Worth and Insider Trading

Martin A. Lehr Net Worth

The estimated net worth of Martin A. Lehr is at least $2 Million dollars as of 2024-05-22. Martin A. Lehr is the CEO of Context Therapeutics Inc and owns about 979,891 shares of Context Therapeutics Inc (CNTX) stock worth over $2 Million. Details can be seen in Martin A. Lehr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martin A. Lehr has not made any transactions after 2023-02-21 and currently still holds the listed stock(s).

Transaction Summary of Martin A. Lehr

To

Martin A. Lehr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martin A. Lehr owns 1 companies in total, including Context Therapeutics Inc (CNTX) .

Click here to see the complete history of Martin A. Lehr’s form 4 insider trades.

Insider Ownership Summary of Martin A. Lehr

Ticker Comapny Transaction Date Type of Owner
CNTX Context Therapeutics Inc 2023-02-21 director & Chief Executive Officer

Martin A. Lehr Latest Holdings Summary

Martin A. Lehr currently owns a total of 1 stock. Martin A. Lehr owns 979,891 shares of Context Therapeutics Inc (CNTX) as of February 21, 2023, with a value of $2 Million.

Latest Holdings of Martin A. Lehr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNTX Context Therapeutics Inc 2023-02-21 979,891 2.03 1,989,179

Holding Weightings of Martin A. Lehr


Martin A. Lehr Form 4 Trading Tracker

According to the SEC Form 4 filings, Martin A. Lehr has made a total of 11 transactions in Context Therapeutics Inc (CNTX) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Context Therapeutics Inc is the acquisition of 5,823 shares on February 21, 2023, which cost Martin A. Lehr around $4,891.

Insider Trading History of Martin A. Lehr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martin A. Lehr Trading Performance

GuruFocus tracks the stock performance after each of Martin A. Lehr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin A. Lehr is -32.52%. GuruFocus also compares Martin A. Lehr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin A. Lehr within 3 months outperforms 0 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martin A. Lehr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martin A. Lehr

Average Return

Average return per transaction

Outperforming Transactions

7 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.96
Relative Return to S&P 500(%) -10.5

Martin A. Lehr Ownership Network

Ownership Network List of Martin A. Lehr

No Data

Ownership Network Relation of Martin A. Lehr


Martin A. Lehr Owned Company Details

What does Context Therapeutics Inc do?

Who are the key executives at Context Therapeutics Inc?

Martin A. Lehr is the director & Chief Executive Officer of Context Therapeutics Inc. Other key executives at Context Therapeutics Inc include Chief Financial Officer Jennifer Lynn Minai-azary , Chief Legal Officer & Corp. Sec Alex C. Levit , and Chief Medical Officer Tarek Sahmoud .

Context Therapeutics Inc (CNTX) Insider Trades Summary

Over the past 18 months, Martin A. Lehr made 7 insider transaction in Context Therapeutics Inc (CNTX) with a net purchase of 57,118. Other recent insider transactions involving Context Therapeutics Inc (CNTX) include a net purchase of 25,000 shares made by Jennifer Lynn Minai-azary , a net purchase of 6,000 shares made by Alex C. Levit ,

In summary, during the past 3 months, insiders sold 0 shares of Context Therapeutics Inc (CNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Context Therapeutics Inc (CNTX) were sold and 88,118 shares were bought by its insiders, resulting in a net purchase of 88,118 shares.

Context Therapeutics Inc (CNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Context Therapeutics Inc Insider Transactions

No Available Data

Martin A. Lehr Mailing Address

Above is the net worth, insider trading, and ownership report for Martin A. Lehr. You might contact Martin A. Lehr via mailing address: 3675 Market Street, Suite 200, Philadelphia Pa 19104.

Discussions on Martin A. Lehr

No discussions yet.